Ritten raises $35M Series B led by Five Elms Capital
What's the deal? Ritten, a Philadelphia-based startup that builds AI-powered practice management software for behavioural health providers, has raised $35M in a Series B round led by Five Elms CapitalDealroom has a profile for this one. Try Dealroom →. Existing investors Threshold Ventures, 8VC, and Bienville CapitalDealroom has a profile for this one. Try Dealroom → also participated.
Founded in 2020, Ritten unifies electronic medical records, customer relationship management (CRM), and revenue cycle management (RCM) into a single platform for mental health and addiction treatment providers. It handles everything from referrals and admissions to scheduling, charting, compliance, and billing across outpatient and residential settings.
"This partnership with Five Elms will allow us to advance our AI-first roadmap, continue supporting clinicians and staff, and scale solutions that meet the nuanced requirements of behavioral health," said Noah Whitehead, Ritten's chief executive officer.
Why now? Behavioural health has long relied on fragmented, outdated technology ill-suited to the sector's complex compliance and billing needs. Rising demand for mental health and substance use treatment — paired with chronic staff burnout — has made the case for modern, unified software harder to ignore.
Ritten plans to use the funds to deepen its AI capabilities, expand customer support, and build out enterprise features for larger, multi-state treatment organisations.
What could go wrong? Healthcare software is notoriously hard to sell and implement. Behavioural health providers range from single-site clinics to sprawling enterprise groups, each with different workflows and regulatory requirements. Scaling across that spectrum while keeping the product coherent is a real challenge.
Competition is another factor. Established EHR vendors are adding behavioural health modules, and other startups are chasing the same underserved niche.
The signal: Ritten's jump to "breakout" growth stage, per Dealroom, suggests its bet on a single, AI-native system of record is gaining traction in a sector where most providers still juggle multiple legacy tools. The return of all three earlier backers — Threshold Ventures (formerly DFJ), 8VC, and Bienville Capital — alongside a new growth-equity lead signals strong insider confidence that vertical consolidation in behavioural health software is accelerating.
Read more: qubemark.com
